Mostrando 334,001 - 334,020 Resultados de 334,158 Para Buscar '"Integralism"', tiempo de consulta: 1.80s Limitar resultados
  1. 334001
    por Policicchio, Antonio
    Publicado 2006
    “…The test on H8 beam line at CERN during 2004 has given the possibility to test and validate not only the performance of the single spectrometer subsystem but also their integration. The analysis presented in this thesis is to the evaluation of the intrinsic spatial resolution of the tracking system. …”
    Enlace del recurso
  2. 334002
  3. 334003
    por Koetsveld, Folkert
    Publicado 2013
    “…After developing and validating the dierent tools and aspects of the combined t method, it was applied on a somewhat smaller (in terms of integrated luminosity) dataset consisting of events measured in the 7 TeV pp collisions recorded by the ATLAS detector during the 2010 data taking period. …”
    Enlace del recurso
  4. 334004
    por Bernath, Peter F
    Publicado 2005
    “…Direct Product Representations. 4.6. Integrals and Selection Rules. 5. Atomic Spectroscopy. 5.1. …”
    Enlace del recurso
  5. 334005
    por Gomez Ramirez, Andres
    Publicado 2019
    “…This thesis introduces an architecture for improving security in grid computing. The architecture integrates the use of security by isolation, behavior monitoring and deep learning (DL) for the classification of real-time traces of the running user payloads also known as grid jobs. …”
    Enlace del recurso
  6. 334006
    por Wang, Yilong
    Publicado 2022
    “…We perform the first search for this process using the proton-proton collision data collected by the LHCb experiment at centre-of-mass energies of 7 TeV, 8 TeV and 13 TeV, corresponding to an integrated luminosity of 9 fb$^{-1}$. In the analysis, the $\phi$, $J/\psi$ and $\psi(2S)$ resonance regions are removed from the $q^2=m^2(\mu^+\mu^-)$ spectrum. …”
    Enlace del recurso
  7. 334007
    por Ceccarelli, Rudy
    Publicado 2022
    “…With HL-LHC, the Compact Muon Solenoid (CMS) experiment will gather an integrated luminosity up to 4000 fb^{-1} in 10 years, making it possible to study rare events of the Standard Model (SM) or to search for processes beyond it. …”
    Enlace del recurso
  8. 334008
  9. 334009
    “…Elevated T1ρ values indicate loss of proteoglycan content that reduces cartilage integrity and could be an initiation point for progression to OA. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 334010
    “…Nous considérons nécessaire la modélisation épidémique du SARS-CoV-2 et de façon générale des maladies infectieuses respiratoires par des méthodes intégrant les dynamiques spatiales des individus, notamment leurs contacts et mobilités effectives. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 334011
    “…The present investigation integrated randomized controlled trials that assessed the effectiveness of platelet-rich plasma injections in managing individuals with Achilles tendon rupture and tendinopathy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 334012
    “…The following caregiver-related and interpersonal determinants were associated with higher caregiver burden: low social support (quantitative study), concerns about the future (qualitative study), the caregiving-induced requirement of restrictions in everyday life (qualitative study), changes in the relationship with the person with PD (qualitative study) and a problem-focused or avoidant coping style (both studies). Integration of both data strands revealed that qualitative findings expanded quantitative findings by (1) distinguishing between the impact of the relationship with the person with PD and the relationship with others on perceived social support, (2) revealing the impact of non-motor symptoms next to motor symptoms and (3) revealing the following additional factors impacting caregiver burden: concern about the future, perceived restrictions and limitations in performing daily activities due to the disease, and negative feelings and emotional well-being. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 334013
    “…Ultimately, the goal is to protect workers’ dignity, the integrity of the organizations, and the welfare of society.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 334014
    “…OBJECTIVES: To (a) assess rates of laboratory monitoring of liver, thyroid, and pulmonary function and adverse events in a pharmacist-managed amiodarone monitoring program compared with usual care in an integrated health care system and (b) estimate return on investment (ROI) from this intervention. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 334015
    “…BACKGROUND: Medication copayment reduction can be integrated with disease management programs to incentivize patient engagement in chronic care management. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 334016
    “…OBJECTIVES: To (a) assess rates of medication adherence and clinical outcomes in the OPCS program compared with usual care in an integrated health care system and (b) estimate return-on-investment (ROI) from this intervention. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 334017
    “…Responders at week 24 (IGF-I <1.3 × ULN and mean integrated GH <2.5 ng/mL) were randomized to receive OOC or iSRLs during the subsequent randomized controlled treatment (RCT) phase.(1) Multivariate logistic regression analyses were performed to assess the relationship of baseline characteristics with OOC response during the run-in phase by comparing the group randomized to the RCT phase (those responding at end of run-in who opted to continue, n=92) to the group not randomized (n=54). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 334018
    “…Fowler, MD, MHS, Amphliphi Biosciences, Integrated Biotherapeutics; C3J, Armata, Valanbio; Akagera, Aridis, Roche, Astra Zeneca: Advisor/Consultant|Genentech, Regeneron, Deep Blue, Basilea, Janssen;: Grant/Research Support|Infectious Diseases Society of America: Honoraria|MedImmune, Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Merck; Medical Biosurfaces; Locus; Affinergy; Contrafect; Karius;: Grant/Research Support|Novartis, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., MedImmune, Bayer, Basilea, Affinergy, Janssen, Contrafect, Regeneron, Destiny,: Advisor/Consultant|Sepsis diagnostic: Patent pending|UpToDate: Royalties|Valanbio and ArcBio: Stock Options Mark E. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 334019
    “…Fowler, MD, MHS, Amphliphi Biosciences, Integrated Biotherapeutics; C3J, Armata, Valanbio; Akagera, Aridis, Roche, Astra Zeneca: Advisor/Consultant|Genentech, Regeneron, Deep Blue, Basilea, Janssen;: Grant/Research Support|Infectious Diseases Society of America: Honoraria|MedImmune, Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Merck; Medical Biosurfaces; Locus; Affinergy; Contrafect; Karius;: Grant/Research Support|Novartis, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., MedImmune, Bayer, Basilea, Affinergy, Janssen, Contrafect, Regeneron, Destiny,: Advisor/Consultant|Sepsis diagnostic: Patent pending|UpToDate: Royalties|Valanbio and ArcBio: Stock Options David van Duin, MD, PhD, Entasis: Advisor/Consultant|Merck: Advisor/Consultant|Merck: Grant/Research Support|Pfizer: Advisor/Consultant|Pfizer: Honoraria|Qpex: Advisor/Consultant|Roche: Advisor/Consultant|Shionogi: Advisor/Consultant|Shionogi: Grant/Research Support|Union: Advisor/Consultant|Utility: Advisor/Consultant…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 334020
    “…Fowler, MD, MHS, Amphliphi Biosciences, Integrated Biotherapeutics; C3J, Armata, Valanbio; Akagera, Aridis, Roche, Astra Zeneca: Advisor/Consultant|Genentech, Regeneron, Deep Blue, Basilea, Janssen;: Grant/Research Support|Infectious Diseases Society of America: Honoraria|MedImmune, Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Merck; Medical Biosurfaces; Locus; Affinergy; Contrafect; Karius;: Grant/Research Support|Novartis, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., MedImmune, Bayer, Basilea, Affinergy, Janssen, Contrafect, Regeneron, Destiny,: Advisor/Consultant|Sepsis diagnostic: Patent pending|UpToDate: Royalties|Valanbio and ArcBio: Stock Options…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS